Results - Announcements
Sanjivani Paranteral Ltd share price ticked higher by 3.52% to Rs 173.55 after the company's net profit soared by 66.67% to Rs 4.15 crore, while revenue from operations slightly gained 6.25% to Rs 25.33 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, rising 5.04%. It has marginally improved by 2.99% over last one week and crept higher by 2.72% in last one month while the market capitalization of Sanjivani Paranteral Ltd has inched up 4.72% and 8.72% in the same period respectively.
Profit before tax (PBT) of Sanjivani Paranteral Ltd stood at Rs 5.53 crore in Q3 FY26, surging by 152.51% year-on-year, and rallying 66.57% quarter-on-quarter. EBITDA came in at Rs 6 crore, jumping 205.26% YoY and expanding by 58.71% sequentially.
Total expenses marginally dropped 3.99% to Rs 19.51 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 12.09 crore, slumping by 22.85% YoY, while employee benefits expense was at Rs 2.47 crore, inching up 5.11% YoY.
For the TTM ended FY26, revenue from operations eased 2.04% to Rs 68.67 crore, while net profit contracted by 17.31% to Rs 6.69 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 873% to Rs 9.22 crore, and PBT softened 9.28% to Rs 9.39 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 0.03 crore in FY26, as against Rs 12.4 crore in FY25.
Sanjivani Paranteral Ltd tumbled by 18.25% in last one year, underperforming the benchmark BSE Sensex which has softened by 7.38% during the same period.